Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Correvio Pharma Corp.
CORV
Healthcare
Drug Manufacturers - Major
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial...
Fibrillation, Hospital Acquired Pneumonia & Community Acquired Pneumonia, Pulmonary Arterial Hypertension, and Su
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CORV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
slithey
X
View Profile
View Bullboard History
Comment by
slithey
on Apr 13, 2020 5:24pm
RE:RE:why it is very risky to invest?
This is nearly following William Hunter's playbook with angiotech some years ago: develop a drug product with decent sales, expand through acquisitions taking on debt at high interest that were
...more
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Mar 05, 2020 4:10pm
RE:RE:RE:+50% today!
I wasn't far off, apparently Xydalba was mentioned on ABC News as used in the corona treatment according to people on Stocktwits
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Mar 05, 2020 3:53pm
RE:RE:+50% today!
could it be anything to do with the Zevtera drug used against pneumonia? I bet some of these corona patients develop bacterial pneumonia also following the viral pneumonia
(60)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 24, 2020 11:16am
still holding this stock
using dollar cost averaging for this one and it is going up today with markets crashing,so glta.
(23)
•••
shareswapper
X
View Profile
View Bullboard History
Post by
shareswapper
on Feb 13, 2020 11:13am
Is Correvio Getting Bought By Cipher?
On SEDAR Cipher has posted "Articles of Amalgamation" with Cardiome Corporation which I bleieve was Correvios former name? Can someone help me here? https://sedar.com/CheckCode.do
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 30, 2019 11:42pm
RE:RE:Aww man this was supposed to be my early retirement 🤢
if China approves Brinavess we could go back to $2 easy IMHO, they are not as fussy as FDA which still bans the cyclamate although the whole world allows it
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 28, 2019 6:27pm
RE:Aww man this was supposed to be my early retirement 🤢
there are still IPCI, MDNA, TLT and ONC, ha
(0)
•••
ZackDoyle43
X
View Profile
View Bullboard History
Post by
ZackDoyle43
on Dec 24, 2019 10:29pm
Something on CORV
ICYM l https://cutt.ly/srrijJl
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 23, 2019 12:16am
RE:RE:RE:RE:RE:RE:why it is very risky to invest?
may be there be good news tomorrow and Happy Holidays to everybody {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=tt14DzZbB78|(fs)True|(loop)False|(autoplay
...more
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 17, 2019 10:36am
RE:RE:RE:RE:RE:why it is very risky to invest?
Consequently, on December 10, 2019, the FDA voted against approval of the NDA. On this news, Correvio shares fell 67% to close at $0.46 per share. The stock continues to decline. Read more at https
...more
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 16, 2019 2:55pm
RE:RE:RE:RE:why it is very risky to invest?
bought some more today to average down for the fraction of the price I paid when it was above $3, remember that it was in the $4's a year ago without any US Brinavess, let's go, hee
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 12, 2019 10:35pm
RE:RE:RE:why it is very risky to invest?
it's still too early to bury CORV because they'll make $30 mil, in revenue this year. Their problem has been too many expenses but now they're saying they''ll cut them in N.America
...more
(36)
•••
mingzhu
X
View Profile
View Bullboard History
Comment by
mingzhu
on Dec 12, 2019 9:48pm
RE:RE:why it is very risky to invest?
it does not mean much even FED approves Treyent because CORV has no right to sell in U.S. Only United tech has U.S right. CORV can only use the document to apply for approval in EU. It will take long
...more
(62)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Dec 12, 2019 5:36pm
RE:lawsuits start now
there can be no lawsuit until FDA has officially rejected the re-application on Dec.24(Happy Xmas) and it's still up in the air what will be decided
(36)
•••
mingzhu
X
View Profile
View Bullboard History
Post by
mingzhu
on Dec 12, 2019 4:50pm
lawsuits start now
https://ca.finance.yahoo.com/news/important-investor-alert-schall-law-214200544.html
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
New electric industrial heat technology to reduce greenhouse gas emissions
Discover Options Trading Strategies to Minimize your Tax Burden
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle
Learn About a Mining Portfolio of More Than 250 Projects and Royalties Across North America